Versor Investments’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Versor Investments’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,108,845	Closed	-$53.2M	–	328
2020 Q1	$53.2M	Buy	1,108,845 +106,196	+11%	+$4.94M	3.53%	15
2019 Q4	$47.1M	Buy	+1,002,649	New	+$44.3M	2.38%	18

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Versor Investments's RARX Position: Q2 2020 in Review

Versor Investments sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 1,108,845 shares — an estimated $53.2M sold.

Versor Investments first reported a position in RARX in Q4 2019 and held it in 2 quarters. The position peaked at $53.2M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Versor Investments reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Versor Investments sold 1,108,845 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $53.2M.
Versor Investments first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 2 quarters.
Versor Investments's Ra Pharmaceuticals, Inc. Common Stock position peaked at $53.2M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Versor Investments's 13F filing for Q2 2020, filed 30 Jul 2020.